ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IQV IQVIA Holdings Inc

252.57
0.00 (0.00%)
Pre Market
Last Updated: 04:05:32
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price
Ask Price
News -
Day High

Low
167.42

52 Week Range

High
261.73

Day Low
Company Name Stock Ticker Symbol Market Type
IQVIA Holdings Inc IQV NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 252.57 04:05:32
Open Price Low Price High Price Close Price Prev Close
252.57
Trades Volume Avg Volume 52 Week Range
0 0 - 167.42 - 261.73
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 252.57 USD

IQVIA Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
45.84B 181.50M - 14.98B 1.36B 7.48 33.76
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

IQVIA News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No IQV Message Board. Create One! See More Posts on IQV Message Board See More Message Board Posts

Historical IQV Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week254.13256.29247.48251.43815,759-1.56-0.61%
1 Month250.02261.73244.00253.30900,9912.551.02%
3 Months219.11261.73205.38232.631,031,48933.4615.27%
6 Months201.97261.73167.42215.001,165,09050.6025.05%
1 Year189.43261.73167.42211.141,103,89563.1433.33%
3 Years191.04285.61165.75220.901,020,15261.5332.21%
5 Years141.80285.6181.79188.321,116,745110.7778.12%

IQVIA Description

IQVIA Holdings Inc is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The Technology & Analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Your Recent History

Delayed Upgrade Clock